Read the full story from BizJournals here. Cancer diagnostics company Exact Sciences Corp. has more than doubled the capital investment and job creation numbers it proposed under an agreement with the Wisconsin Economic Development Corp., according to documents obtained by the Milwaukee Business Journal per a public records request. In 2015, Madison-based Exact Sciences was approved […]

Read the full story from WISCONSIN INNO here. The University of Wisconsin-Milwaukee and Froedtert & the Medical College of Wisconsin have partnered on an app that provides real-time communication between doctors that treat patients whose cancer has spread to the brain. The app, called NIMBLE, also provides data-driven treatment recommendations for doctors and references to […]

Read the full press release on Business Wire here. Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Roche, a global pioneer in pharmaceuticals and diagnostics, today announced a 15-year, non-exclusive collaboration agreement to broaden the adoption of distributable next-generation sequencing-based (NGS) testing in oncology. As the understanding of genomic […]

Read the full press release from Empirico here. Empirico Inc. announced today that it has entered into a strategic collaboration with Ionis Pharmaceuticals. During the three-year collaboration, Empirico will utilize its Precision Insights Platform, which incorporates huge biological data sets, human genetics and advanced algorithmic approaches, to identify therapeutic targets for indications and tissues that are amenable […]

Read the full press release from BusinessWire here. BioForward names biohealth industry leaders to Board of Directors MADISON, Wis.–(BUSINESS WIRE)–BioForward, Wisconsin’s state association representing over 220 biohealth member companies, announced seven additions to this year’s Board of Directors. The board of eighteen represents many facets of the state’s diverse biohealth industry and focuses on uniting […]

Read the full press release here. Promega Corporation today announced it has signed a license agreement with MilliporeSigma, a leader in genome editing, to access MilliporeSigma’s foundational CRISPR genome-editing technology. Under the agreement, Promega will create new research products for investigating endogenous biology, including those for drug development. These tools will allow researchers to better […]

Read the full press release from BusinessWire here. TAI Diagnostics Announces New Publication using the myTAIHEART® Test in The Journal of Heart and Lung Transplantation TAI Diagnostics, Inc., focused on developing innovative diagnostic tests for monitoring the health of transplanted organs, today announced the publication of “Donor Fraction Cell-Free DNA and Rejection in Adult and […]

Read the full story from BizTimes here. Madison-based cancer diagnostics company Exact Sciences Corp. completed its $2.8 billion cash-and-stock deal with Redwood City, California-based Genomic Health, the company announced. Exact Sciences produces Cologuard, a noninvasive, at-home screening test that detects the presence of colon cancer in stool samples. Genomic Health develops Oncotype IQ, a portfolio of genomic […]